Dermatology · Cape Girardeau, MO
NPI
1487712295
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1359 N Mount Auburn Rd
Cape Girardeau, MO, 63701
Phone (573) 335-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
34,655 services
Medicare patients, 2024
3,408
Average age 76
Drug cost, 2024
$588K
1,029 prescriptions
Company payments, 2025
$17K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles M Moon was code 17003 (destruction skin lesion), 8,427 times for 1,185 patients. In total Charles M Moon billed 34,655 services in 137 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 8,427 | 1,185 | $4.57 | $38K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 7,500 | 23 | $107.74 | $808K |
| 88305 Surgical Pathology Examination | Office | 3,853 | 2,122 | $50.97 | $196K |
| 99213 Office E&M - Established | Office | 3,028 | 2,017 | $58.67 | $178K |
| 17000 Destruction Skin Lesion | Office | 2,082 | 1,477 | $32.14 | $67K |
| 99214 Office E&M - Established | Office | 1,097 | 795 | $87.31 | $96K |
| 11102 Skin Biopsy | Office | 1,014 | 841 | $54.92 | $56K |
| 17311 Mohs Surgery | Office | 839 | 661 | $414.85 | $348K |
| 17110 Destruction Skin Lesion | Office | 673 | 586 | $67.89 | $46K |
| 17312 Mohs Surgery | Office | 501 | 326 | $301.10 | $151K |
| 11103 Skin Biopsy | Office | 408 | 263 | $34.39 | $14K |
| 88342 Immunohistochemistry | Office | 388 | 339 | $76.01 | $29K |
| 88341 Immunohistochemistry | Office | 365 | 196 | $65.83 | $24K |
| 99212 Office E&M - Established | Office | 361 | 320 | $37.68 | $14K |
| 13132 Wound Repair - All Levels | Office | 339 | 309 | $180.61 | $61K |
By year: 2022 $2.9M for 40,845 services; 2023 $2.7M for 37,614 services; 2024 $2.7M for 34,655 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 3,853 | 2,122 | $50.97 | $196K |
| 88342 Immunohistochemistry | 388 | 339 | $76.01 | $29K |
| 88341 Immunohistochemistry | 365 | 196 | $65.83 | $24K |
| 88312 Surgical Pathology Examination | 174 | 165 | $79.87 | $14K |
| 88304 Surgical Pathology Examination | 31 | 29 | $29.16 | $904 |
| 87220 General Laboratory | 17 | 15 | $4.18 | $71.06 |
| Q0112 All potassium hydroxide (koh) preparations | 13 | 13 | $5.71 | $74.23 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles M Moon prescribed most often to Medicare patients was Fluorouracil, with 93 prescriptions and refills. In total Charles M Moon wrote 1,029 Medicare prescriptions that cost $588K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluorouracil Generic | 93 | 95 | 87 | $7,756 |
| Clobetasol Propionate Generic | 92 | 105 | 62 | $7,625 |
| Doxycycline Hyclate Generic | 80 | 141 | 54 | $1,817 |
| Triamcinolone Acetonide Generic | 67 | 71 | 56 | $729 |
| Cephalexin Generic | 64 | 64 | 62 | $289 |
| Ciprofloxacin Hcl Generic | 55 | 55 | 52 | $299 |
| Ketoconazole Generic | 49 | 58 | 34 | $828 |
| Fluticasone Propionate Generic | 48 | 48 | 45 | $752 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 35 | 35 | 30 | $7,523 |
| Gentamicin Sulfate Generic | 32 | 32 | 22 | $1,199 |
| Mupirocin Generic | 31 | 31 | 26 | $212 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 27 | 27 | 26 | $98.32 |
| Mometasone Furoate Generic | 26 | 26 | 26 | $528 |
| Dupixent Pen Dupilumab | 24 | 24 | Under 11 | $91K |
| Betamethasone Dipropionate Generic | 24 | 24 | 23 | $978 |
Brand drugs: 135 claims; generic drugs: 894 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles M Moon $17K ($17K in general payments such as food, travel and fees) from 17 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 12 | $15K |
| Abbvie Inc. ABBV | 20 | $340 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $260 |
| UCB, Inc. UCB.BR | 6 | $254 |
| Genzyme Corporation SNY | 5 | $122 |
| Janssen Biotech, Inc. JNJ | 3 | $107 |
| LEO Pharma Inc. | 3 | $104 |
| Amgen Inc. AMGN | 4 | $91.26 |
| Botanix SB Inc | 5 | $89.75 |
| ConvaTec Inc. CTEC.L | 2 | $80.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.